Nutrition
Volume 26, Issue 5 , Pages 556-562, May 2010

Hypolipidemic effect of the polysaccharide from Pholiota nameko

Tianjin Key Laboratory of Food Biotechnology, Faculty of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, Peoples Republic of China

Received 26 May 2009; accepted 1 June 2009. published online 08 October 2009.

Abstract 

Objective

This study was conducted to investigate the hypolipidemic effect of the polysaccharide isolated from Pholiota nameko (PNPS-1).

Methods

Hyperlipidemic Wistar rats were treated with PNPS-1 (20, 40, and 60mg/kg orally).

Results

Treatment of hyperlipidemic Wistar rats with PNPS-1 led not only to significant decreases in very low-density lipoprotein/low-density lipoprotein cholesterol (−48.98% and −21.54%, 40 and 60mg/kg), triacylglycerol (−19.70%, −17.17%, −32.32%), phospholipids (−9.90%, −19.80%, −27.08%), and consequently the atherogenic index (23.61%, 70.42%, 82.85%) and a increase in high-density lipoprotein cholesterol (69.01% and 73.35%, 40 and 60mg/kg) in serum, but also to significant decreases in total lipids (−10.24% and −33.16%, 40 and 60mg/kg), total cholesterol (−24.22%, −34.26%, −55.02%), triacylglycerol (−22.53% and −38.50%, 40 and 60mg/kg), and phospholipids (−27.41%, 60mg/kg) in the liver. Further, PNPS-1 significantly suppressed lipid peroxidation by decreasing malondialdehyde and increasing antioxidant enzymes in serum (malondialdehyde, 9.94%, −22.22%, −32.75%; superoxide dismutase, 37.26%, 101%, 114%; catalase, 32.2%, 30.02%, 36.74%; glutathione peroxidase, 31.30%, 35.56%, 52.34%) of the 20-, 40-, and 60-mg/kg PNPS-1 groups and in the liver (malondialdehyde, −32.26%, −47.85%; catalase, 97%, 117%; glutathione peroxidase, 70.70%, 78.03%) in the 40- and 60-mg/kg PNPS-1 groups (superoxide dismutase, 24.35%, 67.49%, 234%). PNPS-1 was also effective in lowering body weight and some visceral weights (liver, heart, and kidney) in treated rats, except for the lung. PNPS-1 also ameliorated the pathologic changes in coronary arteries of hyperlipidemic rats.

Conclusion

These results suggested that PNPS-1 significantly suppresses the development of hyperlipidemia and might be used as a potential therapeutic agent for hyperlipidemia.

Keywords: Cholesterol, Hypocholesterolemia, Lipid profile, Pholiota nameko, Polysaccharide

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0899-9007(09)00248-2

doi:10.1016/j.nut.2009.06.009

Nutrition
Volume 26, Issue 5 , Pages 556-562, May 2010